
|Videos|July 15, 2021
Treatment-Resistant Depression: Financial Support for Esketamine Therapy
Advertisement
Episodes in this series

Recommendations that can help clinicians navigate through the reimbursement process and best support patients who receive intranasal esketamine for treatment-resistant depression.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Kratom Component in Clinical Trial for Opioid Use Disorder
2
NIDA Awards PleoPharma $6.5 Million Grant to Advance Phase 3 Trial of PP-01 for Cannabis Use Disorder
3
Why Cultural Context Matters in Psychiatric Assessment
4
FDA Feedback Paves Way for New IND Filing for PT00114 in Generalized Anxiety Disorder
5





